Background

Elmiron Eye Injury Lawsuits

Have you suffered eye damage after taking Elmiron?

Speak To An Attorney
Elmiron

Elmiron use linked to macular degeneration

Studies have shown that patients taking Elmiron have an increased risk for developing serious eye damage that could lead to blindness. Symptoms of macular degeneration include:

  • Eye pain
  • Distorted vision
  • Vision loss
  • Blurred vision
  • Difficulty reading
  • Difficulty adjusting to darkness

Elmiron eye injury lawsuits

Patients who have taken Elmiron to treat bladder pain due to interstitial cystitis and have suffered eye damage have filed lawsuits against Janssen Pharmaceuticals the maker of Elmiron for failing to warn doctors and patients of the risk of serious injury. If you or someone you know has taken Elmiron and has suffered vision loss, contact us. Our product liability attorneys have represented thousands of people in litigation against drug manufacturers like Janssen and helped them get compensation for their injuries.

CTA back

Take Action — Contact CohenMalad, LLP Today

Meet Our Pharmaceutical Litigation Team

Our legal team has spent years fighting against big pharmaceutical companies that put dangerous drugs on the market. We have the resources, experience, and aggressive litigation skills needed to win these cases.

When you hire CohenMalad, LLP, you’re not just getting an attorney — you’re getting a team of fighters dedicated to securing justice for victims like you.

about us
Team photo

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

The name is invalid
The last name is invalid
The phone is invalid
The email is invalid
This field is required
This field is required
This field is required
      This field is required

      By providing a telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt out of further messaging.

      Thank you!
      Your message has been submitted
      Oops! Something went wrong while submitting the form.